Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe Publications section description now states that entries are automatically filled from PubMed, replacing the previous wording. The revision number was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check22 days agoChange DetectedTaiwan study locations were updated: two new entries for Tainan, Taiwan 701 and 704 were added, and the corresponding Tainan City, Taiwan 701 and 704 entries were removed.SummaryDifference0.1%

- Check37 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT02580058. The content remains focused on trial design, eligibility, interventions, and outcomes.SummaryDifference0.1%

- Check66 days agoChange DetectedCore content updated with government funding status and operating details; version bumped to v3.2.0. Deletion of a specific resource listing (Genetic and Rare Diseases Information Center resources: Ovarian cancer) and removal of the older revision tag (v3.0.2).SummaryDifference1%

- Check80 days agoChange DetectedRemoved a 'Back to Top' link; no significant content or data changes.SummaryDifference0.0%

- Check87 days agoChange DetectedAdded MedlinePlus Genetics topic: Ovarian cancer and updated to revision v3.0.2; removed the previous revision tag v3.0.0-post.1-g752effb-HEAD.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.